Navigation Links
JDP Therapeutics, Inc. Appoints Christopher M. Cashman to Board of Directors
Date:6/18/2010

JDP Therapeutics, Inc., a specialty pharmaceutical company, announced today the appointment of Christopher M. Cashman to its Board of Directors. Mr. Cashman has an impressive track record in heading start-up pharmaceutical companies and advancing them to exit in addition to having over 30 years of industry experience.

Lansdale, Pennsylvania (PRWEB) June 18, 2010 -- JDP Therapeutics, Inc., a specialty pharmaceutical company, announced today the appointment of Christopher M. Cashman to its Board of Directors. Mr. Cashman has an impressive track record in heading start-up pharmaceutical companies and advancing them to exit in addition to having over 30 years of industry experience.

"Chris has been an invaluable advisor to JDP since its inception working along side founder Jie Du, Ph.D. for the past two years. He has played an integral role in the company’s success to date and we are thrilled that Chris has decided to become a formal member of the team,” said Josh Tarnoff, JDP’s CEO and Executive Board Member. “On a personal note, he is highly respected and well known for his strong integrity and relationships in both the corporate and investment communities.”

Christopher Cashman is co-founder of Protez Pharmaceuticals Inc. and served as Director, President and CEO. Protez was acquired by Novartis in 2008. He was the recipient of the “Entrepreneur of the Year” award at the 2008 MAC Alliance Conference and the “Life Sciences CEO of the Year” by the Eastern Technology Council. He currently also serves on the Board of Directors of Noble Biomaterials, MBF Therapeutics and the Science Center.

“It has been a pleasure working with Jie on the start-up phase of JDP, and now with Josh on board as CEO, JDP is well positioned to advance JDP-205 into the clinic,” said Mr. Cashman.

Company founder Jie Du, Ph.D. added, “The timing for Chris to join our team is especially fitting as we are now poised to move our flagship product into Phase I clinical trial development. We are excited that he will continue to share in our growth and help guide the Board through this very important phase.”

JDP Therapeutics Inc., founded in 2008, is a specialty pharmaceutical company focused on developing small molecule therapeutics to treat life threatening diseases with significant unmet medical needs, primarily for acute care use in the hospital setting.

For further information, please call 215-661-8557 or email info(at)jdptherapeutics(dot)com.

###

Read the full story at http://www.prweb.com/releases/JDP_Therapeutics/Pharmaceuticals/prweb4159384.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Osseon Therapeutics, Inc. Announces it has Received Canadian Medical Device Licenses From Health Canada
2. Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast
3. EWI Worldwide Appoints Matt Hubbard President, Exhibit Works Division
4. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
5. Providence Hospital Appoints Four New Members to its Board of Directors
6. iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives
7. Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors
8. Trinity Health Appoints Four to Board of Directors Trinity Health Appoints Four to Board of Directors
9. GeoVax Labs Appoints Two Industry Veterans to Board of Directors
10. Bon Secours Charity Health System Appoints Philip A. Patterson As CEO
11. Touro Appoints Alan Kadish, M.D. President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley ... into Canada to provide its range of unique and advantaged protective solutions ... City that will provide bilingual customer service and marketing support. A new distribution ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency Dennis Fuller ... area, has initiated a fundraiser for a two year old little girl named ... Christmas. To support this beautiful child who is facing life’s journey without her ...
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try ... Clay” the health benefits of integrating clay into a daily diet are numerous, as ... motivational speaker, Perry A~ has since dedicated her life to learning about the benefits ...
(Date:2/8/2016)... ... ... the Rocky Mountain region’s longest running and impressive garden and home show where you ... the most incredible gardens and home improvement experts that attend this amazing show. ... 700 14th St. Denver CO, is an exciting event that Performance Mobility has enjoyed ...
(Date:2/8/2016)... Overland Park, KS (PRWEB) , ... February 08, 2016 , ... ... Oils, a leader in Mole removal products. , Moles are derived from a cluster ... can appear in all the wrong places and create a lifetime of embarrassment. Historically, ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today ... ended December 31, 2015, the Company achieved revenue of $8,195,839, ... same quarter in fiscal 2015. --> ... fiscal year 2016 was $2,068,635, or $.03 per share, up ... share, in the Q2 of fiscal year 2015. Gross margin ...
(Date:2/8/2016)... http://www.researchandmarkets.com/research/bcrl3s/labelfree ) ... "Label-Free Detection Market by Technology, Products, Applications ... to their offering. --> http://www.researchandmarkets.com/research/bcrl3s/labelfree ... "Label-Free Detection Market by Technology, Products, ... report to their offering. --> ...
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
Breaking Medicine Technology: